- Record: found
- Abstract: not found
- Article: not found
Economic burden of malignant blood disorders across Europe: a population-based cost analysis
August 2016
August 2016
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<p class="first" id="d14275707e96">Malignant blood disorders are a leading contributor
to cancer incidence and mortality
across Europe. Despite their burden, no study has assessed the economic effect of
blood cancers in Europe. We aimed to assess the economic burden of malignant blood
disorders across the 28 countries in the European Union (EU), Iceland, Norway, and
Switzerland.
</p>